Mohs micrographic surgery and dermatofibrosarcoma protuberans: A multidisciplinary approach in 44 patients

Annals of Plastic Surgery

Volumn 60, Issue 6, 2008, Pages 667-672

  Nelson, Rebecca A ^a   Arlette, John P ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Dermatofibrosarcoma protuberans; Excision; Mohs micrographic surgery; Recurrence rate

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER RECURRENCE; CHEMOSURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKIN BIOPSY; SPLIT THICKNESS SKIN GRAFT; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; CASE REPORT; DISEASE FREE SURVIVAL; EVALUATION; MIDDLE AGED; RETROSPECTIVE STUDY; SKIN TRANSPLANTATION; SKIN TUMOR; TUMOR RECURRENCE;

ADULT; AGED; DERMATOFIBROSARCOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SKIN TRANSPLANTATION;

EID: 45549104375     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31813376a5     Document Type: Article

References (28)

1. Weiss SW, ed. Histological typing of soft tissue tumors. 2nd ed. Berlin: Springer Verlag; 1994:21.
2. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:255-274.
3. Sheehan DJ, Madkan V, Strickling WA, et al. Atrophic dermatofibro-sarcoma protuberans: a case report and reappraisal of the literature. Cutis. 2004;74:237-242.
4. Ah-Weng A, Marsden JR, Sanders DS, et al. Dermatofibrosarcoma protuberans treated by micrographic surgery. Br J Cancer. 2002;87: 1286-1289.
5. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993;28:613-617.
6. Aiba S. Dermatofibrosarcoma protuberans expresses CD34. J Am Acad Dermatol. 194l;30:508.
7. Sigel JE, Bergfild WF, Goldblum JR. A morphologic study of dermatofibrosarcoma protuberans: expansion of a histologic profile. J Cutan Pathol. 2000;27:159-163.
8. Gloster HM Jr, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:82-87.
9. Nouri K, Lodha R, Jimenez G, et al. Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience. Dermatol Surg. 2002;28:1060-1064.
10. Ratner D, Thomas CO, Johnson TM, et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1997;37:600-613.
11. Dawes KW, Hanke CW. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery. Dermatol Surg. 1996;22:530-534.
12. Wacker M, Khan-Durani B, Hartschuh W. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Annals of Surg Oncol. 2004;11:438-444.
13. Stojadinovic A, Karpoff HM, Antonescu CR, et al. Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol. 2000;7:696-704.
14. Sondak VK, Cimmino VM, Lowe LM. Dermatofibrosarcoma protuberans: what is the best surgical approach? Surg Oncol. 1999;8:183-198.
15. Tromovitch TA, Beirne G, Beirne C. Cancer chemosurgery (Mohs' technique). The "chemo-check". Arch Dermatol. 1965;92:291-292.
16. Lang PG Jr, Osguthorpe JD. Indications and limitations of Mohs micrographic surgery. Dermatol Clin. 1989;7:627-644.
17. Pap GS. Mohs micrographic surgery for nonmelanoma skin cancers. Plast Reconstr Surg. 1998;102:1796.
18. Lang, PG Jr. A role for Mohs micrographic surgery in the management of skin cancer and a perspective on the management of the surgical defect. Clin Plast Surg. 2004;5-31.
19. Haas AF, Sykes JM. Mutispeciality approach to complex dermatofibro-sarcoma protuberans of the forehead. Arch Orolaryngol Head Neck Surg. 1998;124:324-327.
20. Bowne WB, Antonescu CR, Leung DH, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88:2711-2720.
21. Sun LM, Wang CJ, Huang CC, et al. Dermatofibrosarcoma protuberans: treatment results of 35 cases. Rad Oncol. 2000;57:175-181.
22. Fiore M, Mceli R, Mussi C, et al. Dermatofibrosarcoma treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23:7669-7675.
23. McArthur G. Molecularly targeted treatment for dermatofibrosarcoma protuberans. Semin Oncol. 2004;31:30-36.
24. Mehrany K, Swanson NA, Heinrich MC, et al. Dermatofibrosarcoma protuberans: a partial response to imatinib therapy. Dermatol Surg. 2006;32:456-459.
25. Snow SN, Gordon EM, Larson PO, et al. Dermatofibrosarcoma protu-berans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer. 2004; 101:28-38.
26. Breuninger H, Schaumberg-Lever G. Control of excisional margins by conventional histopathological techniques in the treatment of skin tumors. An alternative to Mohs' technique. J Pathol. 1988;154:167-171.
27. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer. 1962;15:717-725.
28. McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma protuberans: an analysis of 86 cases, five with metastasis. Ann Surg. 1967;166: 803-816.